{
  "pmcid": "8183183",
  "sha256": "2ea1b517c60cd0ff50ca59aa5f91a260f207726f843810de5a994dc3744d1691",
  "timestamp_utc": "2025-11-10T00:08:43.948961+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.674373401534528,
    "reading_ease": 33.11052429667521,
    "word_count": 276
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial Comparing Morbidity of Local Excision and Total Mesorectal Excision after Neoadjuvant Chemoradiotherapy for Low Rectal Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients with clinical T2/T3 low rectal cancer showing a good response to chemoradiotherapy were randomised to LE or TME"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with clinical T2/T3 low rectal cancer showing a good response to chemoradiotherapy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients were randomised to LE or TME"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare early and late morbidity between local excision (LE) and total mesorectal excision (TME) following neoadjuvant chemoradiotherapy in patients with low rectal cancer."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was surgical morbidity, assessed at 1 month (early) and 2 years (late) post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed centrally, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between March 2007 and September 2012, 148 patients were randomised: 74 to LE and 74 to TME."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Intention-to-treat analysis was conducted on 145 patients."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Early surgical morbidity was significantly lower in the LE group (20%) compared to TME (36%) and completion TME (43%) (P = 0.025). Late surgical morbidity was also lower in the LE group (4%) compared to TME (33%) and completion TME (57%) (P < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No deaths occurred in any group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT00427375."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: National Cancer Institute of France."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}